1022PPopulation-based use of intravenous bisphosphonates in patients newly diagnosed with symptomatic multiple myeloma in Denmark in 2005-2015: Impact of patient characteristics. (23rd October 2018) - Ehrenstein, V; Ording, A G; Ulrichsen, S P; Andersen, I T; Seesaghur, A; Helleberg, C; Silkjær, T; Hernandez, R; Niepel, D; Abildgaard, N